Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-30

Clinical Trial Update: Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

View source ↗

Summary

This document updates a prospective observational cohort study evaluating the efficacy and safety of darolutamide in combination with androgen-deprivation thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darolutamide (darolutamide)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Prostate Cancer | Status: NOT_YET_RECRUITING